Fig. 6From: Evaluating residual tumor after neoadjuvant chemotherapy for muscle-invasive urothelial bladder cancer: diagnostic performance and outcomes using biparametric vs. multiparametric MRIKaplan-Meier survival curves for disease-free survival in patients who received neoadjuvant chemotherapy followed by cystectomy. The survival estimates between three subgroups based on concordance and discordance between MRI and pathology showed significant difference (p < 0.001)Back to article page